Press Releases |
|
| Date | Title | | | 09/03/15 | Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V.| PLAINSBORO, N.J. and AMSTERDAM, The Netherlands, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris® and Salto XT™ ankle replacement products and Tornier's Futura™ silastic toe replacement products, for an undisclosed cash payment. The agreement also includes an option to purchase, in the future, the rig... |
|  | | 08/05/15 | Tornier Reports Second Quarter 2015 Results| Upper Extremity Constant Currency Growth of 11.9% Led by the Aequalis Ascend™ FlexAMSTERDAM, Netherlands, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the second quarter ended June 28, 2015. Revenue for the second quarter of 2015 was $83.2 million compared to second quarter 2014 revenue of $86.9 million, a decrease of 4.2... |
| | | 07/29/15 | Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015| AMSTERDAM, The Netherlands, July 29, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the close of the regular trading market on Wednesday, August 5, 2015. Due to the Company's pending merger with Wright Medical Group, Inc., which, pending FTC clearance, is expected to close in the third quarte... |
| | | 06/18/15 | Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger| Transaction Expected to Close in Third Quarter of 2015, Subject to Receipt of Clearance by FTCMEMPHIS, Tenn. and AMSTERDAM, The Netherlands, June 18, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) today announced that all proposals related to the combination of Wright and Tornier were approved by both Wright's and Tornier's shareholders.
Based on final vote results for Wright, the proposal to adopt the merger agreement and approve the merger... |
| | | 05/05/15 | Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook| Upper extremity constant currency growth of 14.0% led by Aequalis Ascend® Flex™ Total extremities constant currency revenue growth of 9.2% Adjusted gross margin increased by 220 basis points to 77.3%AMSTERDAM, The Netherlands, May 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the first quarter ended March 29, 2015. Revenue for the firs... |
| | | 04/15/15 | Tornier Announces First Quarter 2015 Conference Call| AMSTERDAM, The Netherlands, April 15, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the first quarter ended March 29, 2015 after the close of the regular trading market on Tuesday, May 5, 2015. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time.Tornier... |
| | | 03/10/15 | Tornier Announces U.S. FDA Clearance of Simpliciti(TM) Shoulder System| New Class of Ultra Short-Stem Total Shoulder Arthroplasty Will Increase Access to Treatment for Patients With Compromised Shoulder Function and Severe PainAMSTERDAM, The Netherlands, March 10, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Simpliciti™ Shoulder System, which... |
| | | 02/24/15 | Tornier Reports Fourth Quarter and Full Year 2014 Results and Provides 2015 Outlook| Fourth quarter revenue increased 14.1% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 22.1% led by Aequalis Ascend Flex Full year adjusted gross margin increased by 180 basis points to 76.0%AMSTERDAM, The Netherlands, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the fourth quarter... |
| | | 02/04/15 | Tornier Announces Fourth Quarter and Fiscal Year 2014 Conference Call| AMSTERDAM, The Netherlands, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the fourth quarter and full year ended December 28, 2014 after the close of the regular trading market on Tuesday, February 24, 2015. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 P... |
| | | 01/12/15 | Tornier Announces Preliminary Fourth Quarter and Full Year 2014 Revenue| Fourth Quarter Revenue Increases 11.3% to $92.8 Million Full Year 2014 Revenue of $345.4 Million Represents 11.1% Growth Fourth Quarter Extremities Revenue Grew 16.0% in Constant Currency Over Prior YearAMSTERDAM, The Netherlands, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today preliminary, unaudited fourth quarter and full year 2014 revenue results. Revenue for the fou... |
| | | 11/19/14 | Tornier to Present at Piper Jaffray 26th Annual Healthcare Conference| November 19, 2014AMSTERDAM, The Netherlands, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 26th Annual Healthcare Conference. The Company will participate in a fireside chat presentation that i... |
| | | 11/19/14 | Tornier to Present at Piper Jaffray 26th Annual Healthcare Conference| AMSTERDAM, The Netherlands, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 26th Annual Healthcare Conference. The Company will participate in a fireside chat presentation that is scheduled for T... |
| | | 11/06/14 | Tornier Reports Third Quarter 2014 Results| Revenue increased 14.0% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 20.0% led by Aequalis Ascend Flex Entered into definitive merger agreement with Wright Medical Group on October 27 to create premier high-growth extremities-biologics companyAMSTERDAM, The Netherlands, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, repor... |
| | | 10/27/14 | Wright Medical Group, Inc. and Tornier N.V. Agree to Merge Creating Premier High-Growth Extremities-Biologics Company| October 27, 2014Combination Will Offer Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerates Growth Opportunities in Three of the Fastest Growing Areas in Orthopaedics Adds Significant Scale and Scope to Provide Accelerated Path to Profitability and Stronger Financial Profile Wright Receives Approvable Letter from FDA for Augment® Bone Graft Wright and Tornier Management to Host Joint Conference Call Today at 4:30 p.m. Central TimeMEMPHIS, Tenn. & A... |
| | | 10/27/14 | Tornier Announces Third Quarter 2014 Revenue and Increases 2014 Revenue Guidance| AMSTERDAM, The Netherlands, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced revenue for the third quarter ended September 28, 2014. Tornier's revenue announcement was in conjunction with the announcement today of a definitive agreement to merge with Wright Medical Group, Inc. Tornier's third quarter 2014 revenue totaled $76.7 million, compared to third quart... |
| | | 10/22/14 | Tornier Announces Third Quarter 2014 Conference Call| AMSTERDAM, The Netherlands, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 28, 2014 after the close of the regular trading market on Thursday, November 6, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:... |
| | | 08/07/14 | Tornier Reports Second Quarter 2014 Results| Revenue increased 9.5% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 11.4% led by Aequalis Ascend Flex Increases full year revenue and EBITDA guidanceAMSTERDAM, The Netherlands, Aug. 7, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the second quarter ended June 29, 2014. Revenue for the se... |
| | | 07/10/14 | Tornier Announces Second Quarter 2014 Conference Call| AMSTERDAM, The Netherlands, July 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 29, 2014 after the close of the regular trading market on Thursday, August 7, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Easte... |
| | | 05/08/14 | Tornier to Present at the Bank of America Merrill Lynch 2014 Health Care Conference| AMSTERDAM, The Netherlands, May 8, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference. The Company's presentation is scheduled for Thursday, May 15, 2014 at 8:00 a... |
| | | 05/06/14 | Tornier Reports First Quarter 2014 Results| Revenue increased 6.8% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 9.9% led by Aequalis Ascend Flex U.S. distribution transition progressing from sales force alignment to optimizationAMSTERDAM, The Netherlands, May 6, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the first quarter ended ... |
| | | 04/16/14 | Tornier Announces First Quarter 2014 Conference Call| AMSTERDAM, The Netherlands, April 16, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 30, 2014 after the close of the regular trading market on Tuesday, May 6, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern ... |
| | | 02/24/14 | Tornier Announces Secondary Offering of Ordinary Shares| AMSTERDAM, Netherlands, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the commencement of a proposed underwritten public offering of 5,125,000 ordinary shares by TMG Holdings Coöperatief U.A., an affiliate of Warburg Pincus LLC. Tornier will not sell any ordinary shares in this offering or receive any proceeds from this offering. BofA Merrill Lynch will ac... |
| | | 02/20/14 | Tornier Reports Fourth Quarter and Fiscal Year 2013 Results and Provides 2014 Outlook | Phase 1 of U.S. distribution channel transition complete; Phase 2 underway, with focus on sales force optimization and training New product launches and pipeline on track, led by Aequalis Ascend Flex adoption and expected second quarter launch of Aequalis Reversed in JapanAMSTERDAM, The Netherlands, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financia... |
| | | 02/10/14 | Tornier to Present at the 2014 RBC Capital Markets Global Healthcare Conference| AMSTERDAM, The Netherlands, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 2014 RBC Capital Markets Global Healthcare Conference. The Company's presentation is scheduled for Tuesday, February 25, 2014 at 8:30... |
| | | 02/04/14 | Tornier Announces Fourth Quarter and Full Year 2013 Conference Call| AMSTERDAM, The Netherlands, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 29, 2013 after the close of the regular trading market on Thursday, February 20, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same ... |
| | | 01/13/14 | Tornier Announces Preliminary Fourth Quarter and Full Year 2013 Revenue| Fourth Quarter Revenue Expected to Increase by 5.1% to 6.3% to $83 to $84 MillionAMSTERDAM, The Netherlands, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today preliminary fourth quarter and full year 2013 revenue results. The Company expects revenue for the fourth quarter of 2013 to be in the range of $83 to $84 million, representing growth compared to the yea... |
| | | 12/30/13 | Tornier to Present at 32nd Annual J.P. Morgan Healthcare Conference | AMSTERDAM, The Netherlands, Dec. 30, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference. The Company's presentation is scheduled for Tuesday, January 14, 2014 at 11:00 a.m. Pa... |
| | | 11/20/13 | Tornier to Present at Piper Jaffray 25th Annual Healthcare Conference| AMSTERDAM, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 25th Annual Healthcare Conference. The Company will participate in a fireside chat presentation that is scheduled for Tuesday, December ... |
| | | 11/05/13 | Tornier Reports Third Quarter 2013 Results| U.S. distribution channel transition accelerates with agreements covering 61% of U.S. revenue Non-GAAP gross margin improved to 74.2% Aequalis Ascend Flex™ launch tracking to plan; over 120 trained surgeon usersAMSTERDAM, The Netherlands, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the third quarter ended September 29, 2013. Reven... |
| | | 10/10/13 | Tornier Announces Third Quarter 2013 Conference Call| AMSTERDAM, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 29, 2013 after the close of the regular trading market on Tuesday, November 5, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time.Torn... |
| | | 08/06/13 | Tornier Reports Second Quarter 2013 Results| Achieves Double-Digit Upper Extremity Product Category Growth Improves Non-GAAP Gross Margin Sequentially and Quarter over Quarter to 73.9%Expands OrthoHelix Product Line Reach with First International SaleAMSTERDAM, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremities specialists, reported today its financial results for the second quarter ended June 30, 2013. Revenue for the second quarte... |
| | | 07/15/13 | Tornier Announces Second Quarter 2013 Conference Call| July 15, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 30, 2013 after the market close on Tuesday, August 6, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites all interested pa... |
| | | 05/15/13 | Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Over-Allotment Option| May 15, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the closing of the previously announced underwritten public offering of 8.05 million ordinary shares at a public offering price of $16.15 per ordinary share. The shares sold include 1.05 million ordinary shares sold pursuant to the option to purchase additional shares granted by Tornier and certain exi... |
| | | 05/09/13 | Tornier Announces Pricing of Public Offering of Ordinary Shares| May 9, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the pricing of a previously announced underwritten registered public offering of 7.0 million ordinary shares at a public offering price of $16.15 per ordinary share. The offering is expected to close on or about May 15, 2013. Of the 7.0 million ordinary shares being sold in the offering, 4.5 million sh... |
| | | 05/07/13 | Tornier Reports First Quarter 2013 Results| May 7, 2013Reiterates Revenue and Non-GAAP Adjusted EBITDA Outlook for 2013 Non-GAAP Adjusted Gross Margin Expands 200 Basis Points Year over Year, Excluding Acquisition Related Costs AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the first quarter ended March 31, 2013. Revenue for the first quarter of 2013 reached $82.7 million compar... |
| | | 05/07/13 | Tornier Announces Follow-on Offering of Ordinary Shares| Maay 7, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has commenced an underwritten public offering of 7.0 million ordinary shares. Of the ordinary shares being offered for sale in the offering, Tornier is offering 4.5 million shares and certain existing shareholders are offering 2.5 million shares. The selling shareholders include funds associate... |
| | | 04/26/13 | Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference| April 26, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the Bank of America Merrill Lynch 2013 Health Care Conference. The Company's presentation is scheduled for Wednesday, May 15, at 2:20 p.m. Pac... |
| | | 04/03/13 | Tornier Announces First Quarter 2013 Conference Call| April 3, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 31, 2013 after the market close on Tuesday, May 7, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites all interested part... |
| | | 02/21/13 | Tornier Names David H. Mowry President and Chief Executive Officer| February 21, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer, effective immediately. Sean D. Carney, Chairman of Tornier, commented, "Dave has demonstrated an intensity and concentration in executing on the key initiatives in his charge since joining Tornier in... |
| | | 02/21/13 | Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook| February 21, 2013OrthoHelix Acquisition Closed and Integration Proceeding Smoothly Adjusted EBITDA Margin Improves for both Fourth Quarter and Full Year AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the fourth quarter and fiscal year ended December 30, 2012. Revenue for the fourth quart... |
| | | 02/11/13 | Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference| February 11, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Interim President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the 2013 RBC Capital Markets Global Healthcare Conference. The Company's presentation is scheduled for Wednesday, February 27, at 2:30 p... |
| | | 01/22/13 | Tornier Announces 2012 Fourth Quarter and Full Year Conference Call| January 22, 2013AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2012 after the market close on Thursday, February 21, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier... |
| | | 01/07/13 | Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance| January 7, 2013Full Financial Results Available on February 21, 2013; Company to Present at J.P. Morgan Healthcare Conference on January 7, 2013 AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reiterated today that it expects revenue for the fourth quarter and full year of 2012 to be in the range $75.8 to $78.8 million and $274.0 to $277.0 million, respectively, consistent... |
| | | 12/18/12 | Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference| December 18, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Interim President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the 31st Annual J.P. Morgan Healthcare Conference. The Company's presentation is scheduled for Monday, January 7, at 11:30 a.m. pacific ... |
| | | 11/15/12 | Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference| November 15, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Interim President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the 24th Annual Piper Jaffray Healthcare Conference. The Company's presentation is scheduled for Tuesday, November 27, at 12:30 p.m. eas... |
| | | 11/12/12 | Tornier Appoints David H. Mowry as Interim President and Chief Executive Officer| November 12, 2012Medical Device Industry Veteran Kevin C. O'Boyle Named Interim Vice Chairman AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced the appointment of David H. Mowry as Interim President and Chief Executive Officer, effective immediately. Mr. Mowry succeeds Douglas W. Kohrs, who has retired as President, Chief Executive Officer and Executive Director. A... |
| | | 11/05/12 | Tornier Reports Third Quarter 2012 Financial Results| November 5, 2012Shoulder Products Drive Extremities Constant Currency Growth of 7% OrthoHelix Acquisition Provides Significant New Growth Opportunity AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the third quarter ended September 30, 2012 and updated its fiscal 2012 financial outlook. Sales for th... |
| | | 11/01/12 | Tornier to Present at the Credit Suisse 2012 Healthcare Conference| November 1, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Chief Operating Officer, and Shawn McCormick, the Company's Chief Financial Officer, will be presenting at the Credit Suisse 2012 Healthcare Conference. The Company's presentation is scheduled for Wednesday, November 14, at 7:30 a.m. Mountain time at the Arizona Bil... |
| | | 10/17/12 | Tornier Announces Third Quarter 2012 Conference Call| October 17, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter and nine months ended September 30, 2012 after the market close on Monday, November 5, 2012. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier ... |
| | | 08/24/12 | Tornier to Acquire OrthoHelix Surgical Designs| August 24, 2012Acquisition Is Expected to More Than Double Tornier's Lower Extremity Revenue Transaction Will Bring Innovative Technologies, High Growth, and Strong Gross Margins AMSTERDAM & MEDINA, Ohio--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced that it has signed a definitive agreement to acquire OrthoHelix Surgical Designs, Inc. for $135 million plus additional pa... |
| | | 08/07/12 | Tornier Reports Second Quarter 2012 Financial Results| August 7, 2012Shoulder Products Drive Extremities Constant Currency Growth of 8% Adjusted EBITDA Margin Improves Year Over Year for 4th Consecutive Quarter AMSTERDAM, The Netherlands--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the second quarter of 2012 and updated its fiscal 2012 financial outlook. Sales for... |
| | | 07/18/12 | Tornier Appoints New Chief Financial Officer| July 18, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has appointed Shawn T McCormick as Chief Financial Officer, effective as of September 4, 2012. Mr. McCormick will succeed Carmen L. Diersen, who will depart as Global Chief Financial Officer of Tornier immediately for personal reasons, but will remain as a consultant to Tornier through July 16... |
| | | 07/17/12 | Tornier Announces Second Quarter 2012 Conference Call | July 17, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter and six months ended June 30, 2012 after the market close on Tuesday, August 7, 2012. The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time. Tornier invites a... |
| | | 06/20/12 | Ernst & Young Announces Tornier President & CEO Douglas Kohrs is the Master Entrepreneur Of The Year 2012 Award Winner for the Upper Midwest| June 20, 2012Award Recognizes Entrepreneurial Excellence in Healthcare CategoryMINNEAPOLIS--(BUSINESS WIRE)-- Tornier, Inc., the U.S. operating subsidiary of Tornier NV (NASDAQ: TRNX) announced that Douglas W. Kohrs, President and CEO of Tornier, a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, received the Ernst & Young Master Entrepreneur Of The Year® 2012 Award in the healthcare category for the Upper Midwest. The award recognizes o... |
| | | 06/12/12 | Tornier to Present at the Wells Fargo Securities Research and Economics 2012 Healthcare Conference| June 12, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's Chief Operating Officer, and Carmen Diersen, the Company's Chief Financial Officer, will be presenting at the Wells Fargo Securities Research and Economics 2012 Healthcare Conference. The Company's presentation is scheduled for Tuesday, June 19, at 10:15 a.m. eastern ti... |
| | | 05/08/12 | Tornier Reports First Quarter 2012 Financial Results| May 8, 2012Strong International Sales Drive Global Extremities Constant Currency Growth of 11.4% AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the first quarter of 2012 and updated its fiscal 2012 financial outlook. Sales for the first quarter of 2012 reached $74.5 million compared to first quarter 2... |
| | | 05/01/12 | Tornier to Present at the Bank of America Merrill Lynch 2012 Health Care Conference| May 1, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs, the Company's President and Chief Executive Officer, and Carmen Diersen, the Company's Chief Financial Officer, will be presenting at the Bank of America Merrill Lynch 2012 Health Care Conference. The Company's presentation is scheduled for Tuesday, May 15, at 3:40 p.m. pacific tim... |
| | | 04/13/12 | Tornier Announces 2012 Facility Consolidations| April 13, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it plans to consolidate its facilities to drive operational productivity and to reduce annual operating expenses by $2.3 to $2.8 million beginning in 2013. The Company estimates it will incur restructuring charges of $6.0 to $7.0 million, substantially all of which will be recorded in 2012. Torn... |
| | | 04/10/12 | Tornier Announces First Quarter 2012 Conference Call| April 10, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months ended April 1, 2012 after the market close on Tuesday, May 8, 2012. The Company also announced that Doug Kohrs, President and Chief Executive Officer, and Carmen Diersen, Chief Financial Officer, will host an investor conference call to disc... |
| | | 02/23/12 | Tornier Reports 2011 Financial Results and Provides 2012 Outlook| February 23, 2012Fourth Quarter Sales and Adjusted EBITDA Exceeded Guidance 2012 Outlook Includes Double-Digit Constant Currency Extremities GrowthAMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported its financial results for the fourth quarter and full year 2011 and provided its outlook for financial results in 2012. As previously reported, sa... |
| | | 02/21/12 | Tornier to Present at the 2012 RBC Capital Markets Healthcare Conference| February 21, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs, the Company's President and Chief Executive Officer, and Carmen Diersen, the Company's Chief Financial Officer, will be presenting at the 2012 RBC Capital Markets Healthcare Conference. The Company's presentation is scheduled for Tuesday, February 28, at 3:05 p.m. eastern time at... |
| | | 02/08/12 | Tornier to Highlight Products and Education Programs at American Academy of Orthopedic Surgeons (AAOS) Meeting| February 8, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced it will highlight a range of products and patient education programs at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting ("AAOS") being held February 8-12 in San Francisco, CA. The highlighted products and education programs represent each of Tornier's extremity categories including ... |
| | | 01/27/12 | Tornier Announces 2011 Fourth Quarter and Full Year Conference Call| January 27, 2012AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months and full year ended December 31, 2011, after the market close on Thursday, February 23, 2012. The Company also announced that Doug Kohrs, President and Chief Executive Officer, and Carmen Diersen, Chief Financial Officer, will host an inve... |
| | | 01/09/12 | Tornier Announces Preliminary Fourth Quarter Sales Gain of 12.7% and Full Year 2011 Sales Gain of 14.9%| January 9, 2012Preliminary Fourth Quarter Extremity Product Sales Expand by 17.5% AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists announced preliminary unaudited sales of $69.0 million for the fourth quarter of 2011 compared to sales of $61.3 million for the fourth quarter of 2010, an increase of 12.7%, or 12.4% in constant currency. The compa... |
| | | 12/23/11 | Tornier to Present at the 30th Annual J.P. Morgan Healthcare Conference| December 23, 2011AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs, the Company's President and Chief Executive Officer, and Carmen Diersen, the Company's Chief Financial Officer, will be presenting at the 30th Annual J.P. Morgan Healthcare Conference. The Company's presentation is scheduled for Tuesday, January 10, at 11:00 a.m. pacific time at ... |
| | | 11/08/11 | Tornier Reports Third Quarter 2011 Financial Results| November 8, 2011Extremity Product Sales Growth Reported at 15%, 12% Constant Currency AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported sales of $57.6 million for the third quarter of 2011 compared to sales of $49.7 million for the third quarter of 2010, an increase of 16% as reported and 11% in constant currency. Year to date sales were re... |
| | | 10/12/11 | Tornier Announces Conference Call of Third Quarter Results| AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its third quarter 2011 conference call will be held on Tuesday, November 8, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results. Conference call dial-in information is as follows: U.S. callers: 877 - 673 - 5355 International callers: +1-760 - 666 - 3805 A digital recording will b... |
| | | 08/09/11 | Tornier Reports Second Quarter 2011 Financial Results| August 9, 2011Extremity Product Sales Growth Reported at 19%, 14% Constant Currency; Sales and Adjusted EBITDA Guidance Maintained for 2011 AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported sales of $65.2 million for the second quarter of 2011 compared to sales of $54.6 million for the second quarter 2010, an increase of 19.4% as reported a... |
| | | 08/02/11 | Tornier Announces First Implant in U.S. Clinical Study for the Simpliciti™ Stemless Shoulder Joint Replacement System| August 2, 2011Simpliciti System Also Recently Launched in Europe at Prestigious Annecy Shoulder Course AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced two milestone events for the Company's new SimplicitiTM stemless shoulder joint replacement system. Tornier announced that the first patient has been enrol... |
| | | 07/13/11 | Tornier Announces Conference Call of Second Quarter Results| July 13, 2011AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), announced today its second quarter 2011 conference call will be held on Tuesday, August 9, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results. Conference call dial-in information is as follows: U.S. callers: 877 - 673 - 5355 International callers: +1 - 760 - 666 - 3805 A digital recording will be available 2 hours after the completion of the conf... |
| | | 06/22/11 | Tornier Announces Launch of the Aequalis™ Ascend™ Convertible Shoulder Implant System at the 28th Annual San Diego Shoulder Course| June 22, 2011First Implant Performed in May by Sumant Krishnan, M.DAMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced that its AequalisTM AscendTM Convertible Shoulder System is being launched this week at the 28th Annual San Diego Shoulder Course. The Company also announced that the first implant procedu... |
| | | 05/19/11 | Tornier Introduces Porous Coated Affiniti™ Stem for Shoulder Joint Replacement Surgery | May 19, 2011MINNEAPOLIS--(BUSINESS WIRE)-- Tornier Inc. the operating subsidiary of Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated AffinitiTM Stem for shoulder joint replacement surgery. The Porous Coated Stem, which facilitates device fixation to bone without bone cement, addresses the large se... |
| | | 05/09/11 | Tornier Reports First Quarter 2011 Financial Results| May 9, 2011Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported sales of $69.4 million for the first quarter of 2011 compared to sales of $61.8 million in first quarter 2010, an increase of 12%. First quarter 2011 sales of Tornier's... |
| | | 05/09/11 | INSERTING and REPLACING Tornier Reports First Quarter 2011 Financial Results | May 9, 2011Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA AMSTERDAM--(BUSINESS WIRE)-- Insert "Consolidated Statements of Operations" table before "Condensed Consolidated Balance Sheets" table previously omitted by Business Wire. The corrected release reads: TORNIER REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and ... |
| | | 04/19/11 | Announces Conference Call of First Quarter Results| AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its first quarter 2011 conference call will be held on Monday, May 9, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results. Conference call dial-in information is as follows: U.S. callers: 877-673-5355 International callers: +1-760-666-3805 A digital recording will be available 2 ... |
| | | 04/14/11 | Tornier Announces Launch of BioFiber® Surgical Mesh for Tendon Repair at Arthroscopic Surgery Conference| April 14, 2011BioFiber Expands Tornier Portfolio of Innovative Products for the Repair of Rotator Cuff and Other Tendon Injuries Tornier (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced the launch of its BioFiber® Surgical Mesh for the repair of rotator cuff and other tendon injuries at the 30th Annual Meeting of the Arthroscopic Association of North America Meeting (AANA) held in San Francisco. Utilized to treat over 100 patients since its limited commercial release in... |
| | | 03/07/11 | Tornier Announces Exercise of Underwriters' Option to Purchase Additional Ordinary Shares in IPO| March 7, 2011AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (the "Company") (Nasdaq: TRNX) announced today that the underwriters of its initial public offering exercised their option to purchase an additional 721,274 ordinary shares at a price of $19.00 per share (before underwriters' discounts and commissions) from the Company. The option was granted in connection with the Company's initial public offering of 8,750,000 ordinary shares, which priced on February 2, 2011. The ordinary shares began trad... |
| | | 03/01/11 | Tornier Reports Financial Results for 2010 and Provides 2011 Outlook| March 1, 2011Sales Growth of 13% in 2010 Drives Adjusted EBITDA Increase of 76% Extremity Product Lines Record 15% 2010 GrowthAMSTERDAM, The Netherlands--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported full year sales of $227.4 million in 2010 compared to sales of $201.5 million in 2009, an increase of 13% as reported and 14% in constant currency over t... |
| | | 02/15/11 | Tornier to Highlight Six New Products at American Academy of Orthopaedic Surgeons (AAOS) Meeting| February 15, 2011EDINA, Minn.--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced it will highlight six new products at the American Academy of Orthopaedic Surgeons 2011 Annual Meeting ("AAOS") being held February 15-19 in San Diego, CA. The six new Tornier products address a range of joint replacement, joint repair, and soft tissue repair needs of upper and lower extremity specialist surgeons and their patients. Doug Kohrs, President and CE... |
| | | 02/15/11 | Tornier Announces Conference Call of Fourth Quarter and Year End 2010 Results| February 15, 2011AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its fourth quarter 2010 conference call will be held on Tuesday, March 1, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results. Conference call dial-in information is as follows: U.S. callers: 877-673-5355 International callers: +1-760-666-3805 A digital recording will be available 2 hours after the completion of the conference... |
| | | 02/02/11 | Tornier Prices Initial Public Offering| February 2, 2011AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (the “Company”) announced today the pricing of its initial public offering of 8,750,000 of the Company’s ordinary shares at a price to the public of $19.00 per share, all of which were offered by Tornier N.V. The ordinary shares are expected to begin trading February 3, 2011, on the Nasdaq Global Select Market under the symbol "TRNX." BofA Merrill Lynch and J.P. Morgan Securities LLC acted as joint book-running managers, Piper Jaffray &am... |
| |
|
|
